Nan Shan Life Insurance Co. Ltd. reduced its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 79.1% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 62,424 shares of the company's stock after selling 235,929 shares during the quarter. Nan Shan Life Insurance Co. Ltd.'s holdings in Procter & Gamble were worth $10,638,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Navigoe LLC bought a new stake in Procter & Gamble during the 4th quarter valued at approximately $31,000. Capital A Wealth Management LLC bought a new stake in Procter & Gamble during the 4th quarter valued at approximately $31,000. 10Elms LLP bought a new stake in Procter & Gamble during the 4th quarter valued at approximately $34,000. Mizuho Securities Co. Ltd. boosted its stake in Procter & Gamble by 566.7% during the 1st quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company's stock valued at $34,000 after purchasing an additional 170 shares during the period. Finally, Sunbeam Capital Management LLC bought a new stake in Procter & Gamble during the 4th quarter valued at approximately $34,000. 65.77% of the stock is owned by institutional investors and hedge funds.
Procter & Gamble Stock Up 0.9%
Shares of PG opened at $155.68 on Tuesday. The stock has a market cap of $364.66 billion, a price-to-earnings ratio of 23.91, a P/E/G ratio of 4.07 and a beta of 0.37. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 12 month low of $149.91 and a 12 month high of $180.43. The company has a 50-day moving average price of $157.05 and a two-hundred day moving average price of $163.17.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company had revenue of $20.89 billion during the quarter, compared to analysts' expectations of $20.79 billion. During the same quarter in the previous year, the company posted $1.40 earnings per share. Procter & Gamble's quarterly revenue was up 1.7% compared to the same quarter last year. Equities analysts predict that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were paid a $1.0568 dividend. The ex-dividend date was Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.7%. Procter & Gamble's payout ratio is 64.98%.
Analysts Set New Price Targets
Several analysts recently weighed in on the company. Redburn Atlantic downgraded Procter & Gamble from a "buy" rating to a "neutral" rating and set a $161.00 target price for the company. in a research note on Thursday, May 1st. Wells Fargo & Company decreased their target price on Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. Barclays set a $164.00 target price on Procter & Gamble and gave the stock an "equal weight" rating in a research report on Thursday, July 31st. Bank of America decreased their target price on Procter & Gamble from $190.00 to $180.00 and set a "buy" rating on the stock in a research report on Friday, April 25th. Finally, Erste Group Bank downgraded Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Seven analysts have rated the stock with a hold rating, eleven have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $175.94.
Get Our Latest Research Report on Procter & Gamble
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access